Alta Partners
Alta Partners is a healthcare and life sciences venture capital firm founded in 1996, managing $2.8 billion across 12 funds. It invests in biopharma, medical technology, and healthcare services companies from early stage through exit, serving entrepreneurs building transformative healthcare ventures and institutional investors as Limited Partners.
- Company typePrivate
- Founded1996
- HeadquartersJackson, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Alta Partners does
Alta Partners is a healthcare and life sciences-focused venture capital firm founded in 1996 and headquartered in San Francisco, with additional offices in Jackson, Wyoming and Denver, Colorado. The firm invests across the healthcare spectrum, including biopharma, medical technology, and technology-enabled healthcare services, targeting companies from early stage through IPO or acquisition. Alta's portfolio includes clinical-stage biotechnology companies developing antibody therapeutics, gene-editing platforms for xenotransplantation, in vivo CAR-T therapies, and B cell medicines, alongside healthcare services and digital health companies in mobile care delivery, direct primary care, and consumer health technology. The firm has generated $36 billion in value created with portfolio partners across 119 M&A/IPO events and 75+ FDA approved products over 28+ years.
Alta operates a traditional venture capital model, raising pooled capital through multiple fund vehicles and earning revenue from management fees on committed capital plus performance-based carried interest on successful exits. The firm manages $2.8 billion across 12 funds, including the NextGen Fund series (APNG I–IV) launched from 2017 onward and totaling over $800 million in dedicated capital. Capital is distributed to portfolio companies through direct equity investments, co-leads, and follow-on rounds, while LP capital is sourced from institutional investors including endowments, foundations, pension funds, and family offices through direct outreach and industry relationships. The firm maintains an ArkPes-powered LP portal for investor communications.
The senior investment team is exceptionally lean at four professionals: Managing Partner Dan Janney (with the firm since 1996, 45+ prior portfolio investments), Managing Director Bob More (30 years of life sciences investing, former Gates Foundation Senior Advisor, board seats across multiple portfolio companies), Managing Director Pete Hudson, M.D. (serial healthcare entrepreneur and former Aetna executive), and CFO Larry Randall (with Alta since 2007). The firm's competitive position is built on long-tenured healthcare domain expertise, a broad co-investor network (Arch Venture Partners, OrbiMed, McKesson Ventures, DCM Ventures), and a track record of supporting companies from founding through FDA approval and liquidity events.
Alta Partners firmographics
Firmographics- Name
- Alta Partners
- Legal name
- Alta Partners
- Website
- http://www.altapartners.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Alta Partners is a healthcare and life sciences venture capital firm founded in 1996, managing $2.8 billion across 12 funds. It invests in biopharma, medical technology, and healthcare services companies from early stage through exit, serving entrepreneurs building transformative healthcare ventures and institutional investors as Limited Partners.
- Ownership category
- akta.pro rank
Alta Partners industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Alta Partners is headquartered
LocationHeadquarters
- HQ city
- Jackson
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Alta Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Management Fees: Traditional VC management fees charged on committed capital across 12 funds totaling $2.8 billion AUM. Fees support firm operations and deal sourcing activities.
- Carried Interest: Performance-based carried interest from successful portfolio company exits. The firm has generated $36 billion in value created with partners through 119 M&A/IPO events.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Alta Partners product offering
Product offeringCore offering
Alta Partners is a venture capital firm founded in 1996 that invests in early-stage and growth-stage healthcare and life sciences companies, including biopharma, biotechnology, medical devices, and healthcare services. The firm manages $2.8 billion across 12 funds including the NextGen Fund series (APNG I–IV) totaling over $800 million, and earns revenue through management fees and carried interest from portfolio company exits.
Product overview
Alta Partners is a healthcare venture capital firm founded in 1996, offering investment management across multiple funds. The firm manages $2.8 billion across 12 funds including the AP VIII fund and the NextGen Fund series (APNG I through APNG IV), totaling over $800 million. The firm provides a NextGen Funds LP Portal for investor access. The firm does not offer traditional software products or services; its offerings are investment vehicles for healthcare and life sciences companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Alta Partners NextGen Fund I A venture capital fund vehicle targeting healthcare and life sciences investments, part of the NextGen fund family designed with tailored portfolios. Invested through co-lead, lead, and follow-on equity rounds.
- Alta Partners NextGen Fund II Second fund in the NextGen series, expanding Alta Partners' healthcare and life sciences investment capacity. Provides capital to biopharma, medical devices, and healthcare services companies.
- Alta Partners NextGen Fund III Third fund in the NextGen series, continuing to provide capital to healthcare and life sciences entrepreneurs. Invests in early-stage through growth-stage companies.
- Alta Partners NextGen Fund IV Fourth fund in the NextGen fund family, the most recent vehicle in Alta Partners' healthcare and life sciences investment platform. Provides tailored portfolios with dedicated capital for healthcare investments.
- Alta Partners NextGen Funds LP Portal Investor relations portal for Limited Partners of the NextGen Funds, providing access to fund documents and investor relations materials. Powered by ArkPes platform.
Quantifiable outcome
- 77 FDA approved drugs and products from life sciences portfolio
- +3 more outcomes
Companies that use Alta Partners
Customer profileNamed customers10 records
Segments2 records
Ideal customer profiles2 records
Alta Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Alta Partners partnerships and signals
Strategic signalScale indicators6 records
Recent moves11 records
Expansion highlights6 records
Alta Partners competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights6 records
Customer concentration
Alta Partners social profiles
Digital presenceAlta Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alta Partners leadership team
Management profileNumber of profiles
Profiles9 records
Alta Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alta Partners M&A and investment
M&A and investmentM&A
Investments282 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alta Partners
What does Alta Partners do?
Alta Partners is a venture capital firm founded in 1996 that invests in early-stage and growth-stage healthcare and life sciences companies, including biopharma, biotechnology, medical devices, and healthcare services. The firm manages $2.8 billion across 12 funds including the NextGen Fund series (APNG I–IV) totaling over $800 million, and earns revenue through management fees and carried interest from portfolio company exits.
Is Alta Partners a public or private company?
Alta Partners is a private company. It is classified as management employee owned and is currently operating.
When was Alta Partners founded?
Alta Partners was founded in 1996. It employs 1 to 10 people.
Where is Alta Partners based?
Alta Partners is headquartered in Jackson, United States, in the North America region.
How does Alta Partners make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Does Alta Partners have an API?
No public API is recorded for Alta Partners.
What industry is Alta Partners in?
Alta Partners's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.